Atypical Perinuclear Anti-Neutrophil Cytoplasmic Antibodies in Ocular Inflammatory Diseases

Ocul Immunol Inflamm. 2019;27(6):937-941. doi: 10.1080/09273948.2018.1502787. Epub 2018 Sep 19.

Abstract

Purpose: To characterize the clinical features of patients with ocular inflammatory diseases (OID) who tested positive for atypical perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA). Methods: Retrospective case series of patients with OID seen at the Massachusetts Eye Research and Surgery Institute (MERSI) from April 2014 to April 2016. Results: 813 patients were tested for ANCA with 34 patients (4%) being positive for atypical P-ANCA. Among those with positive atypical P-ANCA, the most frequent diagnoses were anterior uveitis in 62% (n = 21) followed by scleritis in 20% (n = 7). Only one patient had an episode of recurrent disease flare-up. All but one patient, who had concomitant C-ANCA seropositivity and granulomatosis with polyangiitis, had a favorable disease course with controlled inflammation using topical and/or systemic immunomodulatory therapy. Conclusion: In contrast to typical C-ANCA and P-ANCA, atypical P-ANCA seropositivity was not associated with severe vasculitis or poor prognosis in patients with the OID.

Keywords: Anti-neutrophil cytoplasmic antibody; atypical ANCA; ocular inflammatory diseases; scleritis; uveitis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Antineutrophil Cytoplasmic / blood*
  • Child
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Granulomatosis with Polyangiitis / immunology
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Scleritis / diagnosis*
  • Scleritis / immunology*
  • Vasculitis / diagnosis*
  • Vasculitis / immunology*

Substances

  • Antibodies, Antineutrophil Cytoplasmic